- Home
- CAAP vs ADMA Comparison
CAAP vs ADMA Comparison
Compare CAAP & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAAP
- ADMA
- Stock Information
- Founded
- CAAP 1998
- ADMA 2004
- Country
- CAAP Luxembourg
- ADMA United States
- Employees
- CAAP N/A
- ADMA N/A
- Industry
- CAAP Aerospace
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CAAP Consumer Discretionary
- ADMA Health Care
- Exchange
- CAAP Nasdaq
- ADMA Nasdaq
- Market Cap
- CAAP 2.4B
- ADMA 4.7B
- IPO Year
- CAAP 2018
- ADMA N/A
- Fundamental
- Price
- CAAP $19.00
- ADMA $16.97
- Analyst Decision
- CAAP Strong Buy
- ADMA Strong Buy
- Analyst Count
- CAAP 1
- ADMA 4
- Target Price
- CAAP $21.50
- ADMA $15.50
- AVG Volume (30 Days)
- CAAP 88.3K
- ADMA 4.5M
- Earning Date
- CAAP 11-13-2024
- ADMA 11-06-2024
- Dividend Yield
- CAAP N/A
- ADMA N/A
- EPS Growth
- CAAP 114.63
- ADMA N/A
- EPS
- CAAP 2.22
- ADMA 0.15
- Revenue
- CAAP $1,471,077,000.00
- ADMA $330,244,000.00
- Revenue This Year
- CAAP $25.78
- ADMA $60.28
- Revenue Next Year
- CAAP $18.74
- ADMA $13.67
- P/E Ratio
- CAAP $8.53
- ADMA $112.60
- Revenue Growth
- CAAP N/A
- ADMA 58.69
- 52 Week Low
- CAAP $10.57
- ADMA $3.23
- 52 Week High
- CAAP $19.31
- ADMA $21.13
- Technical
- Relative Strength Index (RSI)
- CAAP 60.61
- ADMA 45.02
- Support Level
- CAAP $17.43
- ADMA $15.33
- Resistance Level
- CAAP $19.22
- ADMA $16.97
- Average True Range (ATR)
- CAAP 0.44
- ADMA 0.64
- MACD
- CAAP 0.01
- ADMA -0.03
- Stochastic Oscillator
- CAAP 72.24
- ADMA 62.86
About CAAP Corporacion America Airports SA
Corporacion America Airports SA acquires, develops and operates airport concessions. Its operating segments are geographically divided into Argentina, Italy, Brazil, Uruguay, Ecuador and Armenia. The company generates a majority of its revenue from the Argentina segment. The firm's revenue is categorized into Aeronautical Revenue, Non-Aeronautical Revenue, Commercial Revenue, Construction Service Revenue, and Other Revenue.
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.